The promise of these and other food allergy treatments is immense and research and development, in conjunction with clinical care facilities for food allergy patients, will continue to make more treatment options available for more people in the future.
ARS Pharmaceuticals frames its intranasal epinephrine spray as a needle-free alternative to products such as EpiPen. Though this spray won the backing of an FDA advisory committee, the agency is now requiring that ARS Pharma run another study to support a regulatory submission.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Allermi's $3.5 million seed funding was led by Nelstone Ventures and included participation from FourSight Capital Partners. The company will use the money to expand nationally.
Based in San Francisco, Allermi aims to create a national market for a customizable approach to allergy relief pioneered by a California doctor.
The team behind the World Without Disease Accelerator, part of Janssen Research & Development, one of the Janssen Pharmaceutical companies of Johnson & Johnson, is embracing an ambitious paradigm focused on disease prevention, interception and cure.
Julia Cheek, EverlyWell CEO and cofounder, said in an email that the funding will help the company expand its suite of tests, hire key leadership positions, launch new partnerships and enhance product features this year.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Rising rates of allergies worldwide will cause the global market for allergy diagnostics to nearly triple from $1.3 billion in 2015 to $3.8 billion in 2024, says a new report.
From immunotherapies to mobile health apps, here's how biotech and medtech companies are responding to the rising number of children with food allergies.
There must be some better, more efficient solutions for the essential use of the EpiPen, and Windgap Medical is working on it.
Drug developer Abbott Laboratories is poised to make a $25 billion bid for medical device maker St Jude Medical, allergy free parks could be a thing in the future.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Microbiologist Jason Tetro explains that the best way to protect your child against allergies is to let them get dirty.
As allergies rise, so does the need for on-the-spot epinephrine treatment. Windgap Medical wants to win a chunk of this fast-growing, $1.3 billion market.
Tech entrepreneur Sean Parker just pledged $24 million to Stanford University to set up a new institute for allergy research, and it comes at an important time: We might not be too far, he says, from finding a treatment that’s curative. The new center will be called the Sean N. Parker Center for Allergy Research. It joins a […]
http://www.youtube.com/watch?v=xxdf7MCv8mk Nietzsche may have been thinking of emotional turmoil when he wrote “That which does not kill us makes us stronger,” but the quote could just as easily apply to a potential life science innovation — a cure for peanut allergies. Scientists testing a treatment on children have had positive results from the most unlikely […]
A new smartphone biosensor may provide particularly helpful point-of-care possibilities for medicine in remote locations and developing nations. Researchers at the University of Illinois, Urbana-Champaign are developing a smartphone app plus cradle device that can take food samples and determine whether they have toxins or allergens. It can also detect bacteria and contaminated water, according to […]